UBS Group’s Calamos Convertible Equity Alternative ETF CVRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25
Closed -$908 10605
2025
Q3
$908 Sell
25
-1,205
-98% -$41K ﹤0.01% 9498
2025
Q2
$39.4K Buy
1,230
+77
+7% +$2.29K ﹤0.01% 7968
2025
Q1
$33K Buy
1,153
+867
+303% +$26.2K ﹤0.01% 7880
2024
Q4
$8.58K Buy
+286
New +$8.68K ﹤0.01% 8398
2024
Q3
Sell
-40
Closed -$1.08K 9576
2024
Q2
$1.08K Buy
+40
New +$1.08K ﹤0.01% 8660
2024
Q1
Sell
-118
Closed -$3.18K 9413
2023
Q4
$3.18K Buy
+118
New +$2.94K ﹤0.01% 8003

Other funds holding CVRT

UBS Group's CVRT Position: Q4 2025 in Review

UBS Group sold out of Calamos Convertible Equity Alternative ETF (CVRT) in Q4 2025, closing a stake of 25 shares — an estimated $908 sold.

UBS Group first reported a position in CVRT in Q4 2023 and held it in 6 quarters. The position peaked at $39.4K in Q2 2025. 10 funds tracked by Wall St. Rank hold CVRT as of Q4 2025.

  • UBS Group reported no remaining Calamos Convertible Equity Alternative ETF position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 25 Calamos Convertible Equity Alternative ETF shares in Q4 2025, an estimated $908.
  • UBS Group first reported a position in Calamos Convertible Equity Alternative ETF in Q4 2023 and held it in 6 quarters.
  • UBS Group's Calamos Convertible Equity Alternative ETF position peaked at $39.4K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Calamos Convertible Equity Alternative ETF as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.